(Q46681465)

English

Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model

scientific article published on 26 March 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18367657

Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18367657

1 reference

based on heuristic

inferred from title

author name string

Marie Buléon

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18367657

Julien Allard

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18367657

Acil Jaafar

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18367657

Françoise Praddaude

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18367657

Zara Dickson

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18367657

Marie-Thérèse Ranera

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18367657

Christiane Pecher

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18367657

Jean-Pierre Girolami

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18367657

Ivan Tack

9

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18367657

publication date

26 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18367657

American Journal of Physiology - Renal Physiology

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18367657

294

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18367657

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18367657

F1249-56

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18367657

Leptin deficiency leads to the regulation of kinin receptors expression in mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

Angiotensin-converting enzyme inhibitors versus AT1 receptor antagonist in cardiovascular and renal protection: the case for AT1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

Bradykinin reduces growth factor-induced glomerular ERK1/2 phosphorylation.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

Interleukin-1 inhibits the induction of insulin-like growth factor-I by growth hormone in CWSV-1 hepatocytes

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

Angiotensin-converting enzyme II in the heart and the kidney

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

Bradykinin B2 receptors--a target in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

Vasoactive potential of the b(1) bradykinin receptor in normotension and hypertension.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

The involvement of growth hormone (GH), insulin-like growth factors (IGFs) and vascular endothelial growth factor (VEGF) in diabetic kidney disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

A lipid peroxidation-derived inflammatory mediator: identification of 4-hydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophages

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

The effect of bradykinin on the oxidative state of rats with acute hyperglycaemia

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

Kallikrein gene delivery improves serum glucose and lipid profiles and cardiac function in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

Oxidative and nitrosative stress in acute renal ischemia

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

Prevention of progression and remission/regression strategies for chronic renal diseases: can we do better now than five years ago?

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

Clinical practice. Nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

The AGE-RAGE system and diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

In vivo bradykinin B2 receptor activation reduces renal fibrosis

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

Antihypertensive agents for primary prevention of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

Autocrine activation of the IGF-I signaling pathway in mesangial cells isolated from diabetic NOD mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

Multiple interactions between the renin-angiotensin and the kallikrein-kinin systems: role of ACE inhibition and AT1 receptor blockade

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

4-Hydroxy-2-nonenal: a product and mediator of oxidative stress

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination?

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

A Rapid Method for separating Glomeruli from Rabbit Kidney

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00501.2007

21 January 2018

Identifiers

10.1152/AJPRENAL.00501.2007

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18367657

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18367657

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46681465&oldid=2125948742"